Table 2 Disease activity, damage indices, and physician assessment of disease states among adolescent girls with autoimmune rheumatic diseases
From: Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases
Types | Disease indices | Adolescent girls with autoimmune rheumatic diseases (n = 52) Median (Minimum to Maximum) | |||||
|---|---|---|---|---|---|---|---|
JSLE | SLEDAI-2Â K | 4 (2 to 25) | |||||
SLICC/ACR damage index | 2 (0 to 4) | ||||||
JIA | JADAS-10 | 5 (0 to 33) | |||||
JAD-index | 0 (0 to 2) | ||||||
JDM | MYOACT | 12 (0 to 30) | |||||
MITAX | 5 (0 to 30) | ||||||
N (%) | |||||||
|  | Total (n = 52) | JSLE (n = 21) | JIA (n = 23) | JDM (n = 8) |  | ||
Physician assessment of disease activity states | High disease activity | 7 (13.5) | 3 (14.3) | 3 (13.0) | 1 (12.5) | Montecarlo exact test, p1 = 0.090 p2 = 0.115 p3 = 0.0358* | |
Moderate disease activity | 11 (21.2) | 6 (28.6) | 3 (13.0) | 2 (25.0) | |||
Low disease activity | 13 (25.0) | 6 (28.6) | 3 (13.0) | 4 (50.0) | |||
Remission on medication | 20 (38.5) | 6 (28.6) | 14 (60.9) | 0 (0.0) | |||
Remission off medication | 1 (1.9) | 0 (0.0) | 0 (0.0) | 1 (12.5) | |||